Literature DB >> 26004903

High intrinsic aerobic capacity and pomegranate juice are protective against macrophage atherogenecity: studies in high- vs. low-capacity runner (HCR vs. LCR) rats.

Mira Rosenblat1, Nina Volkova1, Zaid Abassi2, Steven L Britton3, Lauren G Koch3, Michael Aviram4.   

Abstract

We studied the rat model system of high- vs. low-capacity runner (HCR vs. LCR) rats to question the atherogenic properties (oxidative stress, triglycerides and cholesterol metabolism) in the rat macrophages, serum, liver and heart. Half of the LCR or HCR rats consumed pomegranate juice (PJ; 15 μmol of gallic acid equivalents/rat/day) for 3 weeks and were compared to placebo-treated rats. At the end of the study blood samples, peritoneal macrophages (RPM), livers, and hearts were harvested from the rats. RPM harvested from HCR vs. LCR demonstrated reduced cellular oxidation (21%), increased paraoxonase 2 activity (28%) and decreased triglycerides mass (44%). Macrophage uptake rates of fluorescein-isothiocyanate-labeled low-density lipoprotein (LDL) or oxidized LDL were significantly lower, by 37% or by 18%, respectively, in HCR vs. LCR RPM. PJ consumption significantly decreased all the above atherogenic parameters with more substantial beneficial effects observed in the LCR vs. the HCR rats (~80% vs. ~40% improvement, respectively). Similar hypo-triglyceridemic pattern was noted in serum from HCR vs. LCR. In contrast to the above results, liver oxidation and triglycerides mass were both minimally increased in HCR vs. LCR rats by 31% and 28%, respectively. In the heart, lipid content was very low, and interestingly, an absence of any significant oxidative stress, along with modest triglyceride accumulation, was observed. We conclude that HCR vs. LCR rats demonstrate reduced atherogenicity, mostly in their macrophages. PJ exerts a further improvement, mostly in macrophages from LCR rats.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HCR rats; Heart; LCR rats; Liver; Oxidative stress; Pomegranate juice; Rat peritoneal macrophages

Mesh:

Substances:

Year:  2015        PMID: 26004903      PMCID: PMC4578978          DOI: 10.1016/j.jnutbio.2015.04.001

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  40 in total

1.  Usefulness of LDL-C-related parameters to predict cardiovascular risk and effect of pravastatin in mild-to-moderate hypercholesterolemia.

Authors:  Kyoichi Mizuno; Noriaki Nakaya; Tamio Teramoto; Shinji Yokoyama; Yasuo Ohashi; Akio Ueki; Soichiro Takahashi; Yukio Kubota; Haruo Nakamura
Journal:  J Atheroscler Thromb       Date:  2011-11-30       Impact factor: 4.928

2.  Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins.

Authors:  Ruomei Li; Ana Oteiza; Karen Kristine Sørensen; Peter McCourt; Randi Olsen; Bård Smedsrød; Dmitri Svistounov
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-28       Impact factor: 4.052

Review 3.  Aerobic metabolism underlies complexity and capacity.

Authors:  Lauren G Koch; Steven L Britton
Journal:  J Physiol       Date:  2007-10-18       Impact factor: 5.182

Review 4.  Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.

Authors:  R L Tiwari; V Singh; M K Barthwal
Journal:  Med Res Rev       Date:  2008-07       Impact factor: 12.944

Review 5.  Phytosterols and cardiovascular health.

Authors:  Franca Marangoni; Andrea Poli
Journal:  Pharmacol Res       Date:  2010-01-11       Impact factor: 7.658

6.  Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours.

Authors:  Navindra P Seeram; Susanne M Henning; Yanjun Zhang; Marc Suchard; Zhaoping Li; David Heber
Journal:  J Nutr       Date:  2006-10       Impact factor: 4.798

7.  Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease.

Authors:  Michael D Sumner; Melanie Elliott-Eller; Gerdi Weidner; Jennifer J Daubenmier; Mailine H Chew; Ruth Marlin; Caren J Raisin; Dean Ornish
Journal:  Am J Cardiol       Date:  2005-09-15       Impact factor: 2.778

8.  Pomegranate juice protects macrophages from triglyceride accumulation: inhibitory effect on DGAT1 activity and on triglyceride biosynthesis.

Authors:  Mira Rosenblat; Michael Aviram
Journal:  Ann Nutr Metab       Date:  2011-01-06       Impact factor: 3.374

Review 9.  Lactonases with organophosphatase activity: structural and evolutionary perspectives.

Authors:  Dragomir I Draganov
Journal:  Chem Biol Interact       Date:  2010-02-01       Impact factor: 5.192

10.  Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.

Authors:  Yasushi Ishigaki; Hideki Katagiri; Junhong Gao; Tetsuya Yamada; Junta Imai; Kenji Uno; Yutaka Hasegawa; Keizo Kaneko; Takehide Ogihara; Hisamitsu Ishihara; Yuko Sato; Kenji Takikawa; Norihisa Nishimichi; Haruo Matsuda; Tatsuya Sawamura; Yoshitomo Oka
Journal:  Circulation       Date:  2008-06-16       Impact factor: 29.690

View more
  2 in total

Review 1.  Vasculoprotective Effects of Pomegranate (Punica granatum L.).

Authors:  Dongdong Wang; Cigdem Özen; Ibrahim M Abu-Reidah; Sridevi Chigurupati; Jayanta Kumar Patra; Jarosław O Horbanczuk; Artur Jóźwik; Nikolay T Tzvetkov; Pavel Uhrin; Atanas G Atanasov
Journal:  Front Pharmacol       Date:  2018-05-24       Impact factor: 5.810

Review 2.  Possible Beneficial Effects of Fresh Pomegranate Juice in SARS-CoV-2 Infection Conditions.

Authors:  Saleem Ali Banihani
Journal:  J Nutr Metab       Date:  2022-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.